these results show that dyslipidemia hyperinsulinemia and hyperleptinemia are significantly improved and an inflammatory marker is significantly reduced in the experimental group therefore these results suggest that the chromium dairy product is beneficial in the reducing of cardiovascular risk markers and can further prevent and treat cardiovascular disease the dairy product obtained from example 5 is mixed into mouse diet modified labdiet w 35 5 lard pmi u00ae richmond ind usa at 13 weeks of age glucose tolerance tests gtt are performed after an overnight fast according to the results of gtt the kk hlj mice are randomly divided into two groups the experimental group is supplied with a dairy product containing 800 ppb per day of trivalent chromium the control group is not supplied after 7 weeks of chromium supply the kk h1j mice are sacrificed and their hearts are harvested the heart infarction size is evaluated by triphenyltetrazolium chloride ttc staining infarction sizes are revealed on the outer border of hearts in the control mice supplementing the dairy product with chromium and providing it to the experimental mice significantly reduces the myocardial infarction size when compared to the control group p lt 0 05 the dairy product obtained from example 5 is mixed into the mouse diet modified labdiet w 35 5 lard pmi u00ae richmond ind usa at 13 weeks of age glucose tolerance tests gtt are performed after an overnight fast according to the results of gtt the kk hlj mice are randomly divided into two groups the experimental group is supplied with milk powder containing 800 ppb per day of trivalent chromium the control group is not supplied after 7 weeks of chromium supplementation to the diet the kk h1j mice are sacrificed and their.